Deutsche Bank’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $392K | Sell |
38,577
-13,399
| -26% | -$136K | ﹤0.01% | 2568 |
|
|
2025
Q1 | $290K | Sell |
51,976
-5,461
| -10% | -$30.5K | ﹤0.01% | 2745 |
|
|
2024
Q4 | $464K | Buy |
57,437
+18,745
| +48% | +$151K | ﹤0.01% | 2613 |
|
|
2024
Q3 | $397K | Buy |
38,692
+9,331
| +32% | +$95.6K | ﹤0.01% | 2552 |
|
|
2024
Q2 | $208K | Buy |
29,361
+4,036
| +16% | +$28.5K | ﹤0.01% | 2746 |
|
|
2024
Q1 | $348K | Buy |
25,325
+549
| +2% | +$7.55K | ﹤0.01% | 2482 |
|
|
2023
Q4 | $228K | Sell |
24,776
-967
| -4% | -$8.9K | ﹤0.01% | 2747 |
|
|
2023
Q3 | $156K | Buy |
25,743
+3,808
| +17% | +$23K | ﹤0.01% | 2907 |
|
|
2023
Q2 | $170K | Sell |
21,935
-3,232
| -13% | -$25.1K | ﹤0.01% | 2978 |
|
|
2023
Q1 | $143K | Hold |
25,167
| – | – | ﹤0.01% | 3166 |
|
|
2022
Q4 | $148K | Hold |
25,167
| – | – | ﹤0.01% | 3112 |
|
|
2022
Q3 | $81K | Sell |
25,167
-10,103
| -29% | -$32.5K | ﹤0.01% | 3401 |
|
|
2022
Q2 | $158K | Buy |
35,270
+17,886
| +103% | +$80.1K | ﹤0.01% | 3276 |
|
|
2022
Q1 | $93K | Sell |
17,384
-2,038
| -10% | -$10.9K | ﹤0.01% | 3564 |
|
|
2021
Q4 | $285K | Sell |
19,422
-2,482
| -11% | -$36.4K | ﹤0.01% | 3155 |
|
|
2021
Q3 | $458K | Buy |
21,904
+1,692
| +8% | +$35.4K | ﹤0.01% | 3080 |
|
|
2021
Q2 | $358K | Buy |
20,212
+3,529
| +21% | +$62.5K | ﹤0.01% | 3423 |
|
|
2021
Q1 | $408K | Buy |
16,683
+137
| +0.8% | +$3.35K | ﹤0.01% | 3215 |
|
|
2020
Q4 | $560K | Buy |
16,546
+11,679
| +240% | +$395K | ﹤0.01% | 2811 |
|
|
2020
Q3 | $122K | Buy |
4,867
+422
| +9% | +$10.6K | ﹤0.01% | 3411 |
|
|
2020
Q2 | $150K | Buy |
+4,445
| New | +$150K | ﹤0.01% | 3220 |
|